Melissa A. Starovasnik, Director at Twist Bioscience Corp (TWST), sold 2,500 shares at $68.00 ($170K) on 2026-05-28, disclosed to the SEC on 2026-06-01.
Scheduled sale ($170k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TWST | SELL | 2026-04-03 | $51K | — | Filing → |
| TWST | SELL | 2023-02-13 | $46K | — | Filing → |